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Abstract
The hyaluronan (HA) receptor for endocytosis (HARE) mediates 
the endocytotic clearance of HA and other glycosaminoglycans 
from lymph and blood. Two isoforms of human HARE, 315- and 
190-kDa, are highly expressed in sinusoidal endothelial cells of 
liver, lymph node, and spleen; HARE is also in specialized cells 
in the eye, heart, brain, and kidney. Here we determined whether 
HA binding to HARE initiates intracellular signaling in Flp-In 293 
cells stably expressing either the 315- and 190-kDa HARE or the 
190-kDa HARE alone. HARE was co-immunoprecipitated with ex-
tracellular signal-regulated kinase 1 and 2 (ERK1/2), c-Jun N-ter-
minal protein kinase (JNK), and p38 members of the mitogen-ac-
tivated protein kinase signaling cascade. ERK phosphorylation 
increased in a dose- and time-dependent manner when HA was 
added to cells expressing full-length or 190-kDa HARE, but not 
cells with vector-only or a HARE(ΔLink) construct with greatly de-
creased (~90%) HA uptake. HA did not induce phosphorylation of 
JNK or p38. A maximum increase in phospho-ERK1/2 occurred 
within 30 min at 5 μg/ml HA, and the response was dampened at 
>20 μg/ml HA. HA binding did not increase the level of HARE-ERK 
complexes, but did increase HARE phosphorylation. These find-
ings demonstrate a novel functional response, when HARE binds 
HA, that leads to activation of ERK1/2, important mediators of in-
tracellular signal transduction. 
Abbreviations: HA, hyaluronan; aa, amino acids; BSA, bovine se-
rum albumin; CS, chondroitin sulfate; ECM, extracellular matrix; ERK, 
extracellular signal-regulated kinase; EV, empty vector; GAG, glycos-
aminoglycan; HARE, HA receptor for endocytosis; hHARE, human 
HARE; HRP, horseradish peroxidase; JNK, c-Jun N-terminal kinase; 
MAP kinase, mitogen-activated protein kinase; mAb, monoclonal anti-
body; MEK, mitogen-activated protein kinase/extracellular signal-regu-
lated kinase kinase; pAb, polyclonal antibody; pERK, phosphorylated 
ERK; pJNK, phosphorylated JNK; p-p38 kinase, phosphorylated p38 
kinase; RHAAM, receptor for HA-mediated mobility; tERK, total ERK 
protein; tJNK, total JNK protein; 190-HARE, the 190-kDa HA receptor 
for endocytosis; 315-HARE, the 315-kDa HA receptor for endocytosis
Hyaluronan (HA), a nonsulfated GAG made up of re-peating β(1,4)-d-glucuronic acid-β(1,3)-N-acetyl-d-glu-
co samine disaccharide units, is present in the ECM of all ver-
tebrate tissues. 
HA plays important roles in matrix assembly, cell differen-
tiation, migration, morphogenesis, and wound healing (1–3). 
Elevated levels of HA are associated with various pathologies, 
such as arthritis, inflammation, and cancer (4–7). The aver-
age adult human contains ~15 g of HA, of which ~5 g is syn-
thesized and degraded daily in tissues throughout the body 
(1). Most of the HA and CS types released from tissues dur-
ing this turnover process are ultimately cleared from the cir-
culation and lymph fluid by the HA Receptor for Endocyto-
sis (HARE) (8, 9), also known as Stabilin-2 (10) or FEEL-2 (11). 
Human HARE is encoded by the 180-kb STAB2 gene, found 
on chromosome 12, consisting of 69 exons, and is abundantly 
expressed in the sinusoidal cells of lymph nodes, liver, and 
spleen (8–10, 12, 13). Rat and hHARE in these tissues are pres-
ent as two isoforms (8, 12, 13), e.g. hHARE isoforms are ~190 
and ~315 kDa. Although HARE in the sinusoidal cells of liver 
and lymph node has a known endocytic clearance function, 
it may also have other, not yet described, functions. HARE is 
also expressed in corneal and lens epithelium, in mesenchy-
mal cells of heart valves, in ependymal cells lining the ventri-
cles in the brain, in epithelial cells covering the renal papillae 
(14), and in oviduct (15). The functions of HARE in these latter 
tissues are unknown and might be different from local GAG 
clearance. 
We have stably expressed the recombinant 190-kDa (16) 
and full-length 315-kDa (17) HARE proteins in Flp-In 293 
cell lines, using cDNA derived from human lymph node. 
These Flp-In cell lines have one unique, recombinase-medi-
ated integration site. The full-length 315-kDa HARE is a type 
I membrane protein that contains a 2458-aa extracellular do-
main (with four cysteine-rich fasciclin/epidermal growth 
factor-like domains of unknown function and a LINK do-
main), a transmembrane domain, and a 72-aa cytoplasmic 
domain. The 190-kDa HARE is identical to the C-terminal 
1417 aa of the 315-kDa HARE and is derived from the full-
length protein by proteolytic cleavage (12, 13, 17). 
HARE binds and mediates internalization of HA as well 
as four types of CS (16, 17) via the clathrin-coated pit-medi-
ated endocytic pathway (18, 19). Recent studies demonstrate 
that endocytosis plays an important role in the activation 
and propagation of signaling pathways, such as ERK 1 and 2 
(20, 21), which are members of the mitogen-activated protein 
(MAP) kinase cascade. Multiple reports have documented 
that HA binding to HA receptors CD44 and RHAMM 
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(CD168) triggers signal transduction events through activa-
tion of ERK1/2 (22, 23). MAP kinases are important medi-
ators of signal transduction and play key roles in the regu-
lation of many cellular processes, such as cell growth and 
proliferation, differentiation, and apoptosis. 
In mammalian cells, three major groups of MAP kinases 
have been identified: ERK, JNK, and p38 (24). A common 
feature of the three MAP kinases is that they are typically or-
ganized together in three-kinase modules. The usual ERK 
signaling cascade proceeds through activation of Raf, MEK, 
and then ERK1/2. MAP kinases are stimulated via receptor 
and nonreceptor protein kinases and G-protein-coupled re-
ceptors. MAP kinase cascades are differentially activated by 
a variety of extracellular stimuli, including growth factors, 
cytokines, stress, and ECM components (23, 24). After activa-
tion, MAP kinases are translocated to the nucleus where they 
phosphorylate transcription factors that regulate expres-
sion of immediate-early response genes. This cascade of re-
sponses results in altered levels of proteins that lead to func-
tional and morphological changes of the cell. 
HA signaling through CD44 and RHAMM involves sev-
eral signaling pathways, including the MAP kinase cas-
cade, that lead to HA-dependent functions in various cells 
and tissues; e.g. HA binding to CD44 may regulate hemato-
poiesis by activating the p38 MAP kinase (25). In addition, 
HA-CD44 interactions affect matrix metabolism in articu-
lar chondrocytes via activation of transcription factor NFκB 
and the p38 MAP kinase (26, 27). Furthermore, CD44 and 
RHAMM play pivotal roles in activating oncogenic signal-
ing and HA-mediated tumor cell functions. Overexpression 
of RHAMM strongly correlates with overexpression of Ras 
and ERK, and could be a useful prognostic marker for breast 
cancer progression (28). CD44 and RHAMM form complexes 
with ERK1/2 in invasive breast cancer cells with high basal 
motility (29). An HA-CD44-mediated oncogenic mechanism 
also occurs in ovarian cancer progression (30). 
In the present study, we found that the receptor HARE 
was able to mediate HA-dependent intracellular signal 
transduction and increase the phosphorylation of HARE and 
ERK1/2. This unexpected cell signaling activity of HARE in-
dicates that this receptor is involved in multiple intracellular 
routing or signaling pathways. 
Experimental Procedures
Materials, Solutions, and Buffers—Tris-HCl, glycine, and 
acrylamide were obtained from Research Products Interna-
tional (Mt. Prospect, IL); SDS, Nonidet P-40, and methanol 
were from EMD (Gibbstown, NJ). Protease inhibitor mix-
ture (catalog number P8340 containing 4-(2-aminoethyl)ben-
zenesulfonyl fluoride, aprotinin, leupeptin, bestatin, pep-
statin A, and E-64), sodium pyrophosphate, sodium fluoride, 
sodium orthovanadate, benzamidine, 2-mercaptoethanol, 
EGTA, EDTA, and Tween 20 were obtained from Sigma. 
HA, prepared by bacterial fermentation, was obtained from 
Genzyme Corp. (Cambridge, MA). 125I-Iodine (100 mCi/
ml; specific activity of >0.6 TBq/mg) in NaOH was from GE 
Healthcare. 125I-HA, modified at the reducing end was pre-
pared as described previously (31), Flp-In 293 cells, fetal bo-
vine serum, Dulbecco’s modified Eagle’s medium, and hy-
gromycin B were from Invitrogen. Affinity purified goat 
anti-V5 pAb was obtained from Bethyl Labs (Montgomery, 
TX). Rabbit pAbs against pERK (Thr(P)202 and Tyr(P)204) 
1 and 2 (44- and 42-kDa, respectively), ERK1/2, pJNK 
(Thr(P)183 and Tyr(P)185), JNK, p-p38 MAP kinase (Thr(P)180 
and Tyr(P)182), p38 MAP kinase, and PD 98059 (a MEK in-
hibitor) were obtained from Cell Signaling Technology (Bev-
erly, MA). Protein A/G Plus-agarose, goat anti-rabbit IgG-
HRP, goat anti-mouse IgG-HRP, donkey anti-goat IgG-HRP, 
goat anti-actin (I-19) pAb, antERK2 conjugated to agarose, 
and rabbit anti-ERK2 (C-14, which also recognizes ERK1) 
pAb were from Santa Cruz Biotechnology (Santa Cruz, CA). 
Mouse anti-Tyr(P) (PY-20) mAb was from BD Biosciences 
(San Jose, CA). Western Lightning Chemiluminescence Re-
agent Plus was from PerkinElmer Life Sciences. Nitrocel-
lulose membranes were from Schleicher & Schuell (Dassel, 
Germany). Classic blue autoradiography film BX was from 
MIDSCI (St. Louis, MO). Coomassie Protein Assay Reagent 
was obtained from Pierce. TBS contains 20 mm Tris-HCl, pH 
7.0, 150 mm NaCl. TBST is Tris-buffered saline with 0.1% 
(v/v) Tween 20. Lysis Buffer contains 20 mm Tris, pH 7.2, 
1 mm sodium orthovanadate, 3 mm benzamidine, 2 mm so-
dium pyrophosphate, 5 mm sodium fluoride, 2 mm EGTA, 5 
mm EDTA, 1 μg/ml of protease mixture inhibitor, and 0.5% 
(v/v) Nonidet P-40. 
Cell Lines Expressing 315- or 190-kDa HARE—The con-
struction of 190- and 315-HARE expression vectors, and 
the selection and characterization of stable Flp-In 293 cell 
transfectants are described in detail by Harris et al. (16, 17). 
To make the 190-HARE(Δlink) construct, a single primer 
(5′-CCACTTCCAGGATACCACTGTTCGGATGAAAGAT-
GTGAACTGCACC-3′) was used with the 190-HARE wild 
type template to delete the coding region of the 93-aa Link 
domain. Mutagenesis was performed with pfu Ultra (Strata-
gene) in an EriComp thermal cycler (18 cycles: 94 °C, 30 s; 62 
°C, 30 s; and 71 °C, 1 min/plasmid kb). After these reactions, 
both template and new plasmids were ethanol precipitated 
(0.1 volume of 3 m potassium acetate, pH 5.5, 2 volumes of 
95% ethanol), resuspended in 17 μl of H2O, 2 μl of NEB4 buf-
fer, and 2.5 units of DpnI to digest template plasmids, while 
retaining the intact mutant plasmids. After overnight incu-
bation at 37 °C, the digestion mixtures were heated to 95 °C 
for 10 min and immediately transformed into TOP10 super-
competent Escherichia coli cells. Bacterial cells were screened 
by a Miniprep procedure, PCR, and sequencing to confirm 
the desired mutation. Plasmids containing correct mutations, 
open reading frames, and promoter regions were used to 
make stable cell lines as described (16, 17). Cells stably ex-
pressing recombinant full-length 315-HARE also produce 
the 190-HARE from the full-length protein by proteolysis. 
The cloned and amplified open reading frame for the full-
length 315-HARE from pooled lymph node cDNAs (Mara-
thon system; Clontech) was inserted into expression vector 
pcDNA5/RFT/V5-His-TOPO. Except for the secretion sig-
nal, the same strategy was used for the 190-HARE. Only sta-
ble clones with a single plasmid integrated into the correct, 
unique recombinase-mediated chromosomal site were se-
lected and used, as described (16, 17). 
Cell Lines and Cell Stimulation—Cells expressing full-
length 315-HARE, 190-HARE alone, Flp-In 293 parent cells, 
or cells transfected with vector alone were grown in Dulbec-
co’s modified Eagle’s medium with 8% fetal bovine serum 
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supplemented with 100 μg/ml hygromycin B for at least 2 
days prior to experiments, to 80–90% confluence. Cells were 
washed 2 times with phosphate-buffered saline and incu-
bated in fresh medium without serum for 1 h at 37°C prior 
to starting the experiment. Based on preliminary results (not 
shown) the 1-h incubation in serum-free medium was opti-
mal for observing subsequent HA-induced protein phos-
phorylation. The cells were washed, received fresh serum-
free Dulbecco’s modified Eagle’s medium, and incubated 
with HA at various concentrations for various times at 37 °C, 
as indicated. All experiments used non-animal-derived HA 
with a weight-average molar mass of 580 kDa. For ERK in-
hibition assays, after the 1-h incubation in serum-free me-
dium, cells were pretreated with different concentrations of 
the MEK inhibitor PD 98059 for 30 min and then treated with 
5 or 10 μg/ml of HA for 20 min at 37 °C. Cells were then 
collected by scraping, washed with ice-cold phosphate-buff-
ered saline, and centrifuged at 1,600 × g for 5 min. Cell pel-
lets were incubated with mixing for 1 h at 4 °C in Lysis Buf-
fer, and the lysates were cleared by centrifugation at 14,000 × 
g for 10 min at 4 °C. The cell lysate supernatants were used 
for experiments after determination of protein content (32). 
Immunoblot Analysis—Cell lysates (25 μg of protein) were 
subjected to 5 or 10% SDS-PAGE (33) and electrotrans-
fer to nitrocellulose membranes (34) using a mini-trans-
fer unit (Bio-Rad) for 2 h at 4°Cat 80 V in 25 mm Tris-HCl, 
pH 7.4, 190 mm glycine, and 20% (v/v) methanol. To con-
firm that any differences in band intensity following West-
ern blot analysis were not due to differences in protein load-
ing, the membranes were first stained with 0.1% Ponceau S 
water-soluble stain and photographed. Membranes were 
then washed 4 times for 5 min each with water and incu-
bated with 5% nonfat dry milk in TBST for 1 h at room tem-
perature. The washed membranes were incubated over-
night at 4 °C with pAbs (diluted 1:1000 in 5% milk/TBST) 
to pERK1/2, or ERK1/2, or Abs (diluted 1:1000 in TBST con-
taining 5% BSA) to pJNK, JNK, p-p38 MAP kinase, or p38 
MAP kinase. After washing 3 times for 10 min each in TBST, 
the membranes were incubated with anti-rabbit IgG-HRP 
conjugate, diluted 1:2000 in TBST containing either 5% milk 
(for ERK Abs) or 5% BSA (for JNK and p38 Abs) for 1 h at 
room temperature. 
For Western blot analysis using anti-V5 pAb, membranes 
were incubated in TBST containing 1% BSA for 1 h at room 
temperature, washed, incubated with 1:4000 goat anti-V5 Ab 
for 1 h, washed, and incubated with secondary anti-goat Ab 
conjugated to HRP diluted 1:6000. We used 5% BSA-contain-
ing buffers for blocking nonspecific binding sites and for in-
cubations with anti-Tyr(P) (PY20) mAb, diluted 1:1000. Af-
ter four washes for 10 min each in TBST, ECL and exposure 
to film was utilized for detection according to the manufac-
turer’s instructions. Autoradiography films were scanned 
into digital files, and band densities were quantified, using 
an Alpha Innotech FluoroChem 8000 imaging system (Al-
pha Innotech Corporation, San Leandro, CA), as integrated 
densitometry values (i.e. the sum of all pixel values minus 
background correction). The results are expressed as a ratio, 
e.g. pERK divided by tERK. 
In Figures 1, 2, 5, 6, 7, and 8, the blots shown in the same 
panel were successively stripped and stained with different 
Abs to normalize the results. After one round of detection, 
blots were stripped by washing with water and incubating 
in 62.5 mm Tris-HCl, pH 6.7, 100 mm β-mercaptoethanol, 2% 
SDS at 55 °C for 30 min. After five washings for 10–15 min 
each with TBST, the blots were reprobed with a different Ab 
as above. As a control for gel loading accuracy, bound Abs 
were stripped from the blot and the blot was reprobed with 
anti-actin Ab. The ECL and film method was utilized for de-
tection. Figures show a representative set of Western blots 
from two or usually three independent experiments, which 
gave similar results. 
Immunoprecipitation Assays—Rabbit pAb against ERK2, 
JNK, p38, or mouse anti-Tyr(P) mAb (1 μg/ml) were added 
to cell lysates (200 μg of protein) and incubated with rota-
tion for 2 h at 4 °C. Immune complexes were then collected 
by adding 20 μl of 250 μg/ml Protein A/G Plus Agarose 
and incubated with rotation overnight at 4 °C. The resin was 
washed three times with cold phosphate-buffered saline, the 
pellet was resuspended in 30 μl of 2× Laemmli sample buf-
fer (33), incubated for 3 min at 90 °C, and subjected to SDS-
PAGE and Western blot analysis. We also used three mAbs 
(numbers 30, 154, and 159) raised against rat HARE (9) 
that cross-react with both the 315- and 190-kDa HARE (12). 
HARE was immunoprecipitated, as described above, using 
mAb 30 alone or mAbs 30, 154, and 159 attached to CNBr-ac-
tivated Sepharose (8, 12, 16, 17). ECL and film was utilized 
for detection. 
HA Endocytosis Assays—Cells were grown to ~90% con-
fluence, washed, and incubated for 1 h at37 °Cin Dulbecco’s 
modified Eagle’s medium with 0.5% BSA to allow clearance 
of serum-derived GAGs bound to cell surface HARE. The 
cells were washed and then incubated with 1.5 μg/ml 125I-
HA with and without a 100-fold excess of unlabeled HA (to 
assess specific binding) for 4 h. The cells were then chilled, 
washed, lysed, and radioactivity and protein were deter-
mined (16, 17). 
Statistical Analysis—Data from experimental groups (usu-
ally n = 3) were compared by the unpaired Student’s t test 
using SigmaPlot version 10 (Systat Software, Inc., Point Rich-
mond, CA) and are presented as the mean ± S.E. Values of p 
≤ 0.05 were considered statistically significant. 
Results
HA Treatment Induces HARE Phosphorylation—First, we 
wanted to determine whether HARE is phosphorylated 
on Tyr, because many endocytic, recycling receptors con-
tain Tyr(P) (35, 36), and it is unlikely that HARE would be 
an exception. In addition, the cytoplasmic domain of HARE 
has 4 Tyr that could be phosphorylated (e.g. as assessed by 
NetPhos 2.0). To test this, we used anti-Tyr(P) mAb to pu-
rify Tyr(P)-containing proteins and then Western blot analy-
sis with anti-V5 Ab to detect co-immunoprecipitated recom-
binant HARE (Figure 1A). The 315-kDa HARE was detected 
among Tyr(P)-containing proteins from 315-HARE cells and 
190-kDa HARE was detected in cells expressing 190-HARE 
alone (Figure 1A). Some experiments showed the minor 190-
kDa band present in 315-HARE cells. Neither HARE band 
was present in cells containing empty vector (EV). Also, no 
immunoreactive bands were observed at the HARE band 
positions in control samples using non-immune mouse IgG 
(not shown). 
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We then tested whether HA treatment induced HARE 
phosphorylation in cells expressing 315- or 190-HARE by im-
munoprecipitating HARE with mAb 30 and probing blots 
with anti-Tyr(P) Ab (Figure 1, B and C). Cells were incubated 
for 1 h in serum-free medium, incubated with or without 5 
μg/ml of HA for 20 min, and HARE was then immunoprecip-
itated. Exposing cells to HA increased the amount of Tyr(P) in 
HARE almost 5-fold compared with untreated cells. This oc-
curred in 315-HARE cells containing both the 315- and 190-
kDa HARE (Figure 1B) or in 190-HARE cells expressing just 
the 190-kDa HARE (Figure 1C). When these latter two immu-
noblots were stripped and reprobed using Ab against the C-
terminal V5 epitope (Figure 1, D and E), no differences in the 
amount of receptor expression were detected, confirming that 
exposure to HA enhanced the Tyr phosphorylation of HARE. 
Basal Phosphorylation of MAP Kinases Increases in 315-
HARE or 190-HARE Cells—We addressed the possibility that 
MAP kinases, which are Ser/Thr protein kinases, could be 
phosphorylated in cells expressing HARE. The basal phos-
phorylation level of MAP kinases in Flp-In 293 cells stably 
expressing the full-length 315- and 190-kDa HARE or the 
190-kDa HARE alone were determined by Western blot anal-
ysis using three phospho-specific anti-MAP kinase Abs that 
detect the phosphorylated (active) forms of ERK1 (44 kDa) 
and ERK2 (42 kDa) proteins (Figure 2A), JNK1 (54 kDa) and 
JNK2 (46 kDa) proteins (Figure 2B), or p38 (38 kDa) MAP ki-
nase (Figure 2C). Cells expressing either 315-HARE or 190-
HARE showed 3–4-fold increases in phosphorylated ERK1 
and ERK2 compared with cells transfected with the EV. In 
contrast, we did not find increases in JNK or p38 phosphor-
ylation in cells expressing 190- or 315-HARE. We detected 
no differences in the protein levels of the three MAP kinases 
when immunoblots were reprobed using Abs that recognize 
total ERK, JNK, or p38 proteins. 
HARE and ERK1/2 Form Complexes—We examined whether 
there is a physical interaction between HARE and ERK1 or 
ERK2 in cells expressing 315- and 190 kDa-HARE or 190-kDa 
HARE alone by immunoprecipitating either ERK or HARE 
protein from cell lysates. The associated proteins were then 
cross-probed in Western blots. The 315- and 190-kDa HARE 
were both detected in blots of anti-ERK immunoprecipitates 
(Figure 3A). Consistent with this result, ERK1 and ERK2 were 
detected in anti-HARE immunoprecipitates probed with anti-
ERK Ab (Figure 3B). Cells transfected with EV did not show 
bands (Figure 3, A and B) at the position of either HARE, in-
dicating that the observed complexes were specific and de-
pendent on the presence of both HARE and ERK. Also, no 
HARE-containing immunoreactive material was observed 
in control samples when mouse IgG was used for immuno-
purification or immunoblotting (not shown). Stimulation of 
190-HARE cells with HA did not increase the level of HARE-
ERK complexes, as assessed by co-immunoprecipitation using 
Ab against tERK, which recognizes active pERK plus inactive 
non-phosphorylated ERK (Figure 3C). Taken together, these 
results clearly show that HARE and ERK1 and ERK2 are asso-
ciated with each other as a stable complex in cells expressing 
either the full-length HARE or the 190-kDa isoform. 
HARE and JNK or p38 MAP Kinase Also Form Complexes—
We determined whether there is also an association between 
HARE and the other MAP kinases, JNK and p38. We per-
formed immunoprecipitations with anti-JNK or anti-p38 Ab 
followed by immunoblotting with anti-V5 Ab using 315- or 
190-HARE cells. Association of HARE with JNK (Figure 4A) 
and p38 (Figure 4B) was detected in cells expressing either 
the full-length HARE or 190-kDa HARE alone. No similar 
MAP kinase complexes were found in cells transfected with 
EV. These results demonstrate that both JNK and p38 physi-
cally interact with HARE. 
HA Stimulates ERK Phosphorylation in a Time-dependent 
Way—To examine the activation of ERK1 and ERK2, cells ex-
pressing 315- and 190-kDa HARE, 190-kDa HARE only, or 
EV were incubated for 1 h at 37 °C without serum and then 
with 10 μg/ml HA for various times. Extracts were assessed 
Figure 2. Expression of MAP kinases in 315-HARE and 190-HARE 
cells. Cells expressing 315-HARE, 190-HARE, or EV alone were 
grown to confluence, washed, scraped, and lysed as described under 
“Experimental Procedures.” Lysate samples were analyzed by 10% 
SDS-PAGE and Western blot analysis using anti-pERK (A), anti-pJNK 
(B), or anti-p-p38 (C) Ab, all of which detect activated (phosphorylated) 
forms of ERK1/2 (pERK1/2), JNK (pJNK), and p38 (p-p38) MAP ki-
nases. The same blots were stripped and reprobed with anti-tERK1/2 
or anti-t-p38 Ab, all of which detect total protein. 
Figure 1. HA induces Tyr phosphorylation of HARE. A, cells express-
ing 315-HARE, 190-HARE, or EV alone were cultured in T-25 flasks 
until confluent, washed, scraped, and lysed. Cell lysates (100 μg of 
protein) were immunoprecipitated (IP) with anti-Tyr(P) mAb and the 
immune complexes were subjected to 5% SDS-PAGE and Western 
blot (WB) analysis using anti-V5 pAb as described under “Experimen-
tal Procedures.” Cells expressing 315-HARE (B) or 190-HARE (C) 
cDNA were grown until confluent, washed, incubated for 1 h in me-
dium without serum, and then incubated with (HA) or without (Ctr)5 μg/
ml HA for 20 min. The cells were lysed and 200 μg of total lysate pro-
tein was immunoprecipitated with anti-HARE mAb-30. Immune com-
plexes were collected and subjected to 5% SDS-PAGE and Western 
analysis using anti-Tyr(P) mAb as described under “Experimental Pro-
cedures.” The same blots in B and C were reprobed with anti-V5 Ab 
(D and E, respectively). Immunopurification using non-immune mouse 
IgG served as another control in B–E. The solid and open arrows indi-
cate the positions of the 315-HARE and 190-HARE, respectively. 



























by Western blot analysis for HA-induced changes in ERK ac-
tivation (i.e. phosphorylation). Other results (not shown) in-
dicated that the 1-h incubation in serum-free medium was 
optimal for detection of subsequent HA-induced protein phos-
phorylation. Cells expressing 315- or 190-kDa HARE that were 
exposed to HA showed time-dependent changes in pERK1 and 
pERK2. After 30 min, pERK1 and pERK2 in 315-HARE (Figure 
5, A and D) and 190-HARE (Figure 5, B and E) cells reached a 
maximum that was almost 4- and 8-fold greater, respectively, 
than the time 0 values. Over the next 30 min, pERK1/2 declined 
to baseline levels, due to dephosphorylation of the proteins. El-
evated pERK levels in 315- and 190-HARE cells were statisti-
cally significant at 5 (p = 0.02, p = 0.01, respectively), 15 (p = 0.02, 
p = 0.07, respectively), and 30 min (p = 0.01, p = 0.05, respec-
tively). Control cells transfected with EV, not expressing HARE, 
did not show increased pERK1/2 levels (Figure 5, C and F). 
HARE-mediated Stimulation of ERK 
Phosphorylation by HA Is Dose-depen-
dent—We used increasing HA concen-
trations to assess the concentration de-
pendence of ERK activation in 190-kDa 
HARE cells (Figure 6). As HA increased 
between 0.1 and 5 μg/ml, pERK1 and 
pERK2 increased until reaching a max-
imum at 5 μg/ml (Figure 6, A and C). 
The response then declined at 10 or 20 
μg/ml HA. Total ERK1 and ERK2 pro-
tein levels remained the same. In con-
trast, cells transfected with EV showed 
no activation of ERK1/2 in the presence 
of HA (Figure 6, B and D). Densitomet-
ric analyses of 190-HARE cell samples 
(Figure 6C) revealed a significant (p = 
0.03) 2.5-fold increase in pERK1/2 at 
the lowest HA dose (0.1 μg/ml) used. 
Compared with untreated 190-HARE 
cells, the pERK to tERK ratio was in-
creased about 3-fold (p = 0.001) at 1 μg/
ml HA, 4-fold (p = 0.006) at 5 μg/ml, 
and 2-fold (p = 0.05) at 10 μg/ml (Figure 6C). A similar dose 
response with a maximum increase of pERK1/2 at 5 μg/ml 
was observed in cells expressing full-length 315-kDa HARE 
cDNA (not shown). 
HA Has No Effect on Phosphorylation of JNK and p38 MAP 
Kinase—Next, we determined if there was also activation of 
JNK and p38 MAP kinase, or if there was a differential ac-
tivation of ERK kinases, compared with the other two MAP 
kinases. In contrast to the ERK1/2 results, no time-(Figure 7, 
A and C) or dose-dependent (Figure 7, B and D) increases in 
phosphorylation were observed for either JNK or p38 MAP 
kinase in 190-HARE or 315-HARE (not shown) cells treated 
with HA. These results indicate that HA binding to HARE 
mediates a specific response to activate ERK in cells express-
ing the full-length 315-HARE or 190-HARE alone. 
HA-HARE-mediated ERK Phosphorylation Is Blocked by a MEK 
Inhibitor—We tested the effect of PD 98059, a specific inhibi-
tor of MEK, which is the upstream kinase activator of ERK, on 
HA-induced phosphorylation of ERK in 190- and 315-HARE 
cells. MEK inhibition decreased HA-stimulated pERK levels, 
without affecting the levels of the two ERK or the two HARE 
proteins (Figure 8A). HA-induced ERK phosphorylation was 
greatly inhibited by 50 μm PD 98059 and the pERK to tERK 
ratio was lower than that observed in the absence of inhibitor 
(Figure 8B). Quantification of results from two dose-response 
experiments showed that PD 98059 at 0.1 and 1 μm had no or 
little effect on ERK phosphorylation, whereas 10 μm caused 
a ~30% reduction of ERK activation (Figure 8C). HA-induced 
phosphorylation of ERK was ~70% inhibited by 50 μm PD 
98059, reaching essentially the basal level of pERK1/2 in un-
treated cells. The results support the conclusion that HA bind-
ing to HARE stimulates pERK production by MEK. 
HARE-mediated ERK Activation Requires Its HA-binding Ac-
tivity—To confirm that HA binding to HARE is responsible 
for the intracellular signaling events that activate ERK1/2, 
we assessed the effect of HA on cells expressing a 190-HARE 
mutant lacking the 93-aa Link domain (Figure 9). Compared 
with cells with WT HARE, cells expressing HARE(ΔLink) 
were 90% inhibited in their ability to bind and endocytose 
Figure 4. Detection of HARE-JNK and HARE-p38 MAP kinase com-
plexes. Confluent cultures of 315-HARE, 190-HARE, or EV cells were 
washed and scraped, and lysates were immunoprecipitated (IP) with 
anti-tJNK (A) or anti-t-p38 MAP kinase Ab (B). Immune complexes 
were collected and subjected to SDS-PAGE and Western blot (WB) 
analysis using anti-V5 Ab. Lysates from 315-HARE cells (Ctr) served 
to identify 315- and 190-kDa HARE. The solid and open arrows indi-
cate the positions of 315-HARE and 190-HARE, respectively. 
Figure 3. HARE and ERK form complexes in 315-HARE and 190-HARE cells. Cells expressing 
315-HARE, 190-HARE, or EV were grown to confluence, washed, scraped, lysed, and centrifuged, 
and samples were subjected to immunoprecipitation (IP) with anti-tERK (A) Ab or anti-HARE (B) 
mAbs 30, 154, and 159. Immune complexes were collected and subjected to SDS-PAGE and 
Western blot (WB) analysis using anti-V5 or anti-tERK Ab, as indicated. Lysates from 315-HARE 
cells served as a positive control (Ctr) to identify the positions of 315- and 190-kDa HARE (A), or 
pERK1 and pERK2 (B). The solid and open arrows in A indicate the positions of 315-HARE and 
190-HARE, respectively. C, cells expressing 190-HARE or EV were incubated for 1 h in serum-
free medium, and then incubated as indicated in the presence or absence of 5 μg/ml HA for 20 
min at 37 °C. Cell lysates were immunoprecipitated with anti-ERK2 Ab conjugated to agarose, and 
analyzed as above. As a negative control, release of interfering Ab was estimated by treating rab-
bit IgG-agarose with Laemmli buffer (33). 


























































125I-HA (Figure 9A). In experiments to assess ERK1/2 ac-
tivation in response to HA (as in Figures 5 and 6), the 
HARE(ΔLink) cells showed no detectable ERK phosphoryla-
tion response, even up to 20 μg/ml HA (Figure 9B). Thus, HA 
binding to HARE initiates the intracellular ERK activation 
and signaling processes. The signaling 
response is not due to a contaminant 
in the HA preparations, nor is it due 
to different ligand-binding regions of 
HARE that interact with other endog-
enous ligands (e.g. acetylated-LDL) on 
the cell surface or in the medium. 
Discussion
The results presented here show 
for the first time that HA binding to 
HARE stimulates intracellular sig-
nal transduction pathways associated 
with cellular responses to ECM com-
ponents. The Link domains in many 
HA-binding proteins and receptors are 
directly responsible for their HA bind-
ing activity (37–39). Deleting the Link 
domain of HARE almost completely 
eliminated its ability to mediate HA 
binding and endocytosis, and to stim-
ulate intracellular ERK activation in 
stably transfected cells. 
HA binding induces a time- and 
dose-dependent increase in the phos-
phorylation of ERK1 and ERK2 in cells 
stably expressing either the 315- and 
190-HARE or the 190-HARE alone. After incubation with 
HA for 30 min, phosphorylated ERK1 and ERK2 reached 
maximum levels in both cell types. A maximum increase of 
pERK1/2 occurred at 5 μg/ml HA. In contrast to ERK ac-
tivation, HA (up to 20 μg/ml for 60 min) did not stimulate 
phosphorylation of two other MAP kinases, JNK and p38. In 
the absence of added HA, both HARE isoforms are found in 
stable complexes with all three MAP kinases. HA binding to 
190-HARE cells did not increase the amount of ERK-HARE 
complexes, indicating that HA binding to HARE might in-
duce activation of ERK1/2 in pre-existing complexes. HA 
binding to HARE also resulted in increased phosphorylation 
of HARE on Tyr. HA-induced ERK phosphorylation was 
also diminished ~70% by the MEK inhibitor PD 98059 (50 
μm), which prevents activation (i.e. phosphorylation) of ERK 
by MEK in other cell types (40, 41). 
HARE was first characterized as an endocytic clearance 
receptor that mediates the systematic removal of HA and 
CSs from the circulatory and lymphatic systems (1, 42). 
HARE is highly expressed in the sinusoidal cells of lymph 
nodes, which are the initial and primary sites for the clear-
ance of high molar mass HA (>106 Da) and CS; about 85% 
of the HA entering nodes is degraded. A second HA/CS 
clearance site utilizes HARE in the sinusoidal endothelial 
cells of liver, accounting for degradation of the remain-
ing (~15%) smaller HA that leaves lymph nodes and en-
ters the vascular system (43, 44). HARE is also highly ex-
pressed in spleen, where it may play an as yet unknown 
role in the immune system, and to a lesser extent in other 
tissues, as noted under Introduction. In addition to HA 
and multiple CS types, HARE/Stabilin-2 specifically rec-
ognizes advanced glycation end products (45), and we re-
cently discovered that the 190-HARE and 315-HARE are 
also endocytic receptors for heparin (E. N. Harris, J. A. Wei-
Figure 5.  HA induces time-dependent changes in ERK phosphorylation in 315- and 190-HARE cells. 
Cells expressing 315-HARE (A), 190-HARE (B), or EV (C) were grown to confluence and washed. Af-
ter a 1-h incubation in serum-free medium at 37 °C, the cells were incubated in the presence or ab-
sence of 10 μg/ml HA for 0–30 min as indicated. Lysate samples were then subjected to 10% SDS-
PAGE and Western analysis with Ab against pERK1/2 (top panels). The same blots were stripped 
and reprobed with Ab against tERK1/2 protein (middle panels), and then anti-actin (bottom panels). 
Blots from independent experiments were scanned, densitometry analyses performed, and the nor-
malized results are presented in D (315-HARE, n = 3), E (190-HARE, n = 3), and F (EV, n = 2) as the 
mean ± S.E. of the pERK to tERK ratio (compared with untreated cells at zero time, as 100%). 
Figure 6. HA induces dose-dependent changes in ERK phosphoryla-
tion in 190-HARE cells. Cells stably expressing 190-HARE (A and C) 
or EV (B and D) were grown to confluence, washed, and incubated for 
1 h in serum-free medium at 37 °C. The cells were then incubated for 
20 min at 37 °C with the indicated concentrations of HA, chilled, lysed, 
and samples were analyzed by 10% SDS-PAGE and Western blotting 
with Ab against pERK1/2. The same blots were successively reprobed 
with anti-tERK1/2 Ab to detect total protein and then anti-actin Ab, as in-
dicated. The blots from independent experiments were scanned, densi-
tometry analysis performed, and the normalized results are presented 
as the mean ± S.E. of the pERK to tERK ratio (compared with untreated 
cells, as 100%) for 190-HARE (C, n = 3) and EV (D, n = 2) cells. 
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gel, and P. H. Weigel  J. Biol. Chem. [April 22, 2008] doi: 
10.1074/jbc.M710360200).
Thus, HARE can bind and internalize four different 
classes of ligands. Additionally, ongoing studies indicate 
that the cytoplasmic domain, although small, contains at 
least three redundant motifs for targeting HA-HARE com-
plexes to coated pits (M. S. Pandey, E. N. Harris, J. A. Weigel, 
and P. H. Weigel, unpublished data). Deletion of any of these 
three motifs only partially decreases the rate of endocytosis, 
indicating that HARE complexes might have multiple intra-
cellular routing pathways. Because HARE is expressed in tis-
sues that are not involved in the systemic clearance of HA or 
CS, we have suspected that HARE may have functions other 
than simply ligand clearance. This study supports the pos-
sibility that the HARE isoforms allow cells to sense and re-
spond to a variety of different ECM molecules. 
The HA field has been energized in recent years by the 
elucidation of HA-dependent signaling pathways, providing 
novel insights into the biological functions of this ECM mol-
ecule (23, 46–48). Binding of HA to CD44 or RHAMM stim-
ulates intracellular signal transduction, by activating protein 
phosphorylation, and modifies cell-cell and cell-matrix inter-
actions (22, 23). HA activates several protein Tyr and Ser/Thr 
kinases (including MAP kinases, protein kinase C, focal adhe-
sion kinase, and Src protein Tyr kinase) and thereby promotes 
the expression of specific proteins involved in ECM remodel-
ing and cell differentiation (23). The biology of HA now en-
compasses a wider array of cellular behaviors, in addition to 
its important and well established ECM structural roles. 
Our experiments used non-animal-derived HA with 
a weight-average molar mass of 580 kDa for several rea-
sons. Using HA made by bacterial fermentation avoids arti-
facts due to contaminating mammalian (e.g. umbilical cord-
































bound to the HA. We used the same size HA in previous en-
docytosis studies of the recombinant human 190- and 315-
HARE and know it is bound with high affinity and efficiently 
Figure 7. HA does not induce time- or dose-dependent changes in the 
phosphorylation of JNK or p38 MAP kinase. Cells stably expressing 
190-HARE were grown to confluence, washed, incubated in serum-
free medium for 1 h at 37 °C, and then incubated either with 10 μg/
ml HA for the indicated times (A and C) or with the indicated amounts 
of HA for 1 h (B and D). The cells were then lysed and samples were 
analyzed by SDS-PAGE and Western blotting using Ab against ei-
ther pJNK (A and B) or p-p38 MAP kinase (C and D). The membranes 
were stained with anti-tJNK, successively stripped, and probed with 
anti-t-p38 and then anti-actin Ab, as indicated. 
Figure 8. The MEK inhibitor PD 98059 inhibits HA- and HARE-me-
diated ERK phosphorylation. Cells stably expressing 315-HARE (A 
and C) or 190-HARE (B) were grown to confluence, washed, and in-
cubated in serum-free medium for 1 h at 37 °C. A, the 315-HARE cells 
were incubated with different amounts of PD 98059 for 30 min, as in-
dicated, and then treated for 20 min with 10 μg/ml HA. The cells were 
chilled, lysed, and samples subjected to 10% SDS-PAGE and West-
ern blot analysis using anti-pERK1/2. The same blot was successively 
stripped and reprobed with anti-tERK and then anti-actin Ab, as in-
dicated. A parallel 5% SDS-PAGE was run with the same amount of 
protein and Western blot analysis was performed using anti-V5 Ab to 
identify the 315-HARE (solid arrow) and 190-HARE (open arrow) pro-
teins. B, 190-HARE cells were grown to confluence, washed, incu-
bated in serum-free medium for 1 h at 37 °C and then incubated, as in-
dicated, with or without PD 98059 for 30 min and then without or with 
5μg/ml HA for 20 min. Cell lysates were subjected to SDS-PAGE and 
Western blot analysis using anti-pERK1/2, and the blot was stripped 
and reproved with anti-tERK and then anti-actin Abs, as indicated. C, 
two sets of blots from independent experiments using 315-HARE cells 
were scanned, analyzed by densitometry, and the normalized results 
are expressed as the mean ± S.E. ratio of pERK to tERK; the value 
with no inhibitor present is set to 100%. 







































internalized (16, 17). Finally, it makes sense that cells may 
need to detect and respond to smaller HA fragments with 
more urgency than native high mass HA. Under pathological 
conditions lower molar mass HA can accumulate and affect 
inflammation, angiogenesis, wound healing and cancer (49). 
For example, HA of molar masses up to 950 kDa induces Tyr 
phosphorylation in NCI-H82 cells stably transfected with hu-
man CD44E cDNA (50). 
MAP kinases are a family of evolutionary well conserved 
proteins that are expressed in all eukaryotic cells. They are 
components of signaling pathways that relay, amplify, and 
integrate signals from a variety of extracellular stimuli, thus 
controlling the genomic and physiological response of a cell 
to its environment (24, 28). The three major groups of MAP 
kinases, ERK, JNK, and p38, are Ser/Thr protein kinases. 
Distinct MAP kinase cascades occur in selective activation 
responses to different extracellular stimuli, leading to a wide 
variety of cellular function changes. In this study we found 
that basal pERK1/2 levels in cells stably expressing the full-
length HARE or 190-kDa HARE were >3 times higher than 
in EV cells. In contrast, there was no difference in the basal 
phosphorylation status of JNK or p38 MAP kinase. Further-
more, co-immunoprecipitation results demonstrated an as-
sociation of HARE not only with ERK but also with the two 
other members of the MAP kinase family. Formation of in-
tracellular multiprotein complexes is a mechanism by which 
cells integrate and transmit different signals. We observed 
basal levels of HARE-ERK, HARE-JNK, and HARE-p38 com-
plexes, although only ERK1/2 were activated upon HARE 
binding of HA. We do not know if all three MAP kinases si-
multaneously associate with HARE to create quaternary 
complexes, but this may be likely. RHAMM also associates 
with ERK, but not with JNK or p38 (51). 
Protein phosphorylation, specifically on Ser, Thr, and Tyr 
residues, is one of the most important and widespread post-
translational modifications. Protein phosphorylation regu-
lates many metabolic pathways and also regulates the acti-
vation of signal transduction cascades that in turn regulate 
gene expression and cellular functions (52). To understand 
the molecular basis of these regulatory mechanisms, it is 
necessary to identify the key protein phosphorylation sites. 
The cytoplasmic domain of the 190- and 315-HARE (Tyr2480–
Leu2551) contains four Tyr, seven Ser, one His, and five Thr 
residues (10, 12), although only residues Ser2497, Ser2537, 
Thr2523, Tyr2519, and Tyr2531 are predicted (by NetPhos 2.0) 
to be phosphorylated. As expected, the cytoplasmic domain 
contains several candidate Tyr residues whose phosphoryla-
tion may be HA-mediated. To identify key HARE residues 
in the HARE cytoplasmic domain required for formation of 
HARE-ERK complexes and to mediate the HA-dependent 
activation of ERK-dependent signal transduction pathways, 
we are creating stable cell lines expressing 190-HARE vari-
ants with defined aa substitutions or deletions. 
In summary, we present evidence that HA binding to 
hHARE induces Tyr phosphorylation of HARE and selec-
tively induces the phosphorylation of ERK1 and ERK2 in a 
dose- and time-dependent manner. In contrast, HA binding 
to HARE does not induce the phosphorylation of JNK or p38 
MAP kinase. The conclusion that HA-induced ERK phos-
phorylation is mediated by MEK, an upstream ERK kinase, 
is supported by the inhibitory effect of the MEK inhibitor PD 
98059. Our results indicate that HA binding to hHARE reg-
ulates intracellular Tyr and Ser/Thr protein kinases. This 
study uncovers a novel and previously unknown role for 
hHARE in cell signaling, particularly in activating the ERK 
signaling pathway. 
Acknowledgments — This work was supported by National 
Institutes of Health Grant GM69961 (NIGMS). We thank Jen-
nifer Washburn for technical assistance, and Janet A. Wei-
gel for the purification of anti-HARE mAbs and helpful 
discussions. 
References
1. Laurent, T. C., and Fraser, J. R. E. (1992) FASEB J. 6, 2397–2404
2. Laurent, T. C., Laurent, U. B., and Fraser, J. R. E. (1996) Ann. 
Med. 28, 241–253
3. Toole, B. P. (2001) Semin. Cell Dev. Biol. 12, 79–87
4. Hascall, V. C., Majors, A. K., De la Motte, C. A., Evanko, S. P., 
Wang, A., Drazba, J. A., Strong, S. A., and Wight, T. N. (2004) 
Biochim. Biophys. Acta 1673, 3–12
5. Termeer, C., Sleeman, J. P., and Simon, J. C. (2003) Trends Immu-
nol. 24, 112–114
Figure 9. HA endocytosis and ERK activation are greatly decreased 
in a 190-HARE(ΔLink) mutant. Cells expressing WT or (ΔLink) mutant 
190-HARE or EV were grown and preincubated as described in the 
legend to Figure 6. A, the cells were incubated with 125I-HA for 4 h at 
37°C to assess specific endocytosis. Values are the mean ± S.E. (n 
= 9–12) percent of endocytosis compared with WT (100%), from four 
independent experiments. B, ERK phosphorylation was assessed as 
described in the legend to Figure 6 after incubation with the indicated 
concentrations of HA for 20 min. Lysate samples were then subjected 
to 10% SDS-PAGE and Western analysis with Ab against pERK1/2 
(top panel). The same blot was stripped and reprobed with Ab against 
tERK1/2 protein (middle panel), and anti-actin (bottom panel). 
Hare mediates Ha-dependent signal transduction via extracellular Kinases   15055
6. Bertrand, P., Girard, N., Delpech, B., Duval, C., Danjou, J., and 
Dauce, J. P. (1992) Int. J Cancer 52, 1–6
7. Anttila, M. A., Tammi, R. H., Tammi, M. I., Syrjänen, K. J., Saa-
rikoski, S. V., and Kosma, V. M. (2000) Cancer Res. 60, 150–155
8. Zhou, B., Oka, J. A., Singh, A., and Weigel, P. H. (1999) J. Biol. 
Chem. 274, 33831–33834
9. Zhou, B., Weigel, J. A., Fauss, L. A., and Weigel, P. H. (2000) J. 
Biol. Chem. 275, 37733–37741
10. Politz, O., Gratchev, A., McCourt, P. A. G., Schledzewski, K., 
Guillot, P., Johansson, S., Svineng, G., Franke, P., Kannicht, C., 
Kzhyshkowska, J., Longati, P., Velten, F. W., and Goerdt, S. 
(2002) Biochem. J. 362, 155–164
11. Adachi, H., and Tsujimoto, M. (2002) J. Biol. Chem. 277, 
34264–34270
12. Zhou, B., McGary, C. T., Weigel, J. A., Saxena, A., and Weigel, 
P. H. (2003) Glycobiology 13, 339–349
13. Zhou, B., Weigel, J. A., Saxena, A., and Weigel, P. H. (2002) 
Mol. Biol. Cell 13, 2853–2868
14. Falkowski, M., Schledzewski, K., Hansen, B., and Goerdt, S. 
(2003) Histochem.Cell Biol. 120, 361–369
15. Ulbrich, S. E., Schoenfelder, M., Thoene, S., and Einspanier, R. 
(2004) Mol.Cell. Endocrinol. 214, 9–18
16. Harris, E. N., Weigel, J. A., and Weigel, P. H. (2004) J. Biol. 
Chem. 279, 36201–36209
17. Harris, E. N., Kyosseva, S. V., Weigel, J. A., and Weigel, P. H. 
(2007) J. Biol.Chem. 282, 2785–2797
18. McGary, C. T., Raja, R. H., and Weigel, P. H. (1989) Biochem.J. 
257, 875–884
19. Smedsrod, B., Malmgren, M., Ericsson, J., and Laurent, T. C. 
(1988) Cell Tissue Res. 253, 39–45
20. Pierce, K. L., Maudsley, S., Daaka, Y., Luttrell, L. M., and 
Lefkowitz, R. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 
1489–1494
21. McPherson, P. S., Kay, B. K., and Hussain, N. K. (2001) Traffic 
2, 375–384
22. Entwistle, J., Hall, C. L., and Turley, E. A. (1996) J. Cell. Bio-
chem. 61, 569–577
23. Turley, E. A., Noble, P. W., and Bourguignon, L. Y. W. (2002) J. 
Biol. Chem. 277, 4589–4592
24. Kyosseva, S. V. (2004) Int. Rev. Neurobiol. 59, 201–220
25. Khaldoyanidi, S., Moll, J., Karakhanova, S., Herrlich, P., and 
Ponta, H. (1999) Blood 94, 940–949
26. Hamerman, D., Todaro, J., and Green, H. (1965) Biochim. Bio-
phys. Acta 101, 343–351
27. Ohno, S., Im, H. J., Knudson, C. B., and Knudson, W. (2006) J. 
Biol. Chem. 281, 17952–17960
28. Wang, C., Thor, A. D., Moore, D. H., Zhao, Y., Kerschmann, R., 
Stern, R., Watson, P. H., and Turley, E. A. (1998) Clin. Cancer 
Res. 4, 567–576
29. Hamilton, S. R., Fard, S. F., Paiwand, F. F., Tolg, C., Veiseh, M., 
Wang, C., McCarthy, J. B., Bissell, M. J., Koropatnick, J., and 
Turley, E. A. (2007) J. Biol. Chem. 282, 16667–16680
30. Bourguignon, L. Y. W., Gilad, E., Rothman, K., and Peyrollier, 
K. (2005) J. Biol. Chem. 280, 11961–11972
31. Raja, R. H., LeBoeuf, R. D., Stone, G. W., and Weigel, P. H. 
(1984) Anal. Biochem. 139, 168–177
32. Bradford, M. M. (1976) Anal. Biochem. 72, 248–254
33. Laemmli, U. K. (1970) Nature 227, 680–685
34. Burnette, W. N. (1981) Anal. Biochem. 112, 195–203
35. Haynes, P. H., Oka, J. A., and Weigel, P. H. (1994) J. Biol. Chem. 
269, 33146–33151
36. Mellman, I. (1996) Annu. Rev. Cell Dev. Biol. 12, 575–625
37. Toole, B. P. (1990) Curr. Opin. Cell Biol. 2, 839–844
38. Seyfried, N. T., McVey, G. F., Almond, A., Mahoney, D. J., 
Dudhia, J., and Day, A. J. (2005) J. Biol. Chem. 280, 5435–5448
39. Day, A. J., and Prestwich, G. D. (2002) J. Biol. Chem. 277, 
4585–4588
40. Davies, S. P., Reddy, H., Ciavano, M., and Cohen, P. (2000) Bio-
chem. J. 351, 95–105
41. Bastow, E. R., Lamb, K. J., Lewthwaite, J. C., Osborne, A. C., 
Kavanagh, E., Wheeler-Jones, C. P., and Pitsillides, A. A. 
(2005) J. Biol. Chem. 280, 11749–11758
42. Weigel, P. H., and Yik, J. H. N. (2002) Biochim. Biophys. Acta 
1572, 341–363
43. Fraser, J. R. E., Appelgren, L.-E., and Laurent, T. C. (1983) Cell 
Tissue Res. 233, 285–293
44. Weigel, J. A., Raymond, R. C., McGary, C. T., Singh, A., and 
Weigel, P. H. (2003) J. Biol. Chem. 278, 9808–9812
45. Hansen, B., Longati, P., Elvevold, K., Nedredal, G.-I., Schledze-
wski, K., Olsen, R., Falkowski, M., Kzhyshkowska, J., Carls-
son, F., Johansson, S., Smedsrod, B., Goerdt, S., Johansson, S., 
and McCourt, P. (2005) Exp. Cell Res. 303, 160–173
46. Toole, B. P. (2004) Nature Rev. 4, 528–539
47. Bourguignon, L. Y., Gilad, E., and Peyrollier, K. (2007) J. Biol. 
Chem. 282, 19426–19441
48. Lee, J. Y., and Spicer, A. P. (2000) Curr. Opin. Cell Biol. 12, 
581–586
49. Stern, R., Asari, A. A., and Sugahara, K. N. (2006) Eur. J. Cell 
Biol. 85, 699–715
50. Fujita, Y., Kitagawa, M., Nakamura, S., Azuma, K., Ishii, G., 
Higashi, M., Kishi, H., Hiwasa, T., Koda, K., Nakajima, N., 
and Harigaya, K. (2002) FEBS Lett. 528, 101–108
51. Zhang, S., Chang, M. C., Zylka, D., Turley, S., Harrison, R., and 
Turley, E. A. (1998) J. Biol. Chem. 273, 11342–11348
52. Kim, S. K., and Novak, R. F. (2007) Pharmacol. Ther. 113, 88–120
